Research indicates that dexamethasone, a pre-hydroxylated, synthetic, active form of GC, can enhance gluconeogenesis in mouse HCC by promoting the expression of PEPCK, G6Pase, and FBP1. This evidence concerns the gene FBP1 and hepatocellular carcinoma.